Heartland Bank & Trust CO Bristol Myers Squibb CO Transaction History

Heartland Bank & Trust CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$61.91 - $67.42 $699,830 - $762,115	-11,304 Closed	0 $0
Q1 2021 Jun 21, 2021	SELL	$59.34 - $66.74 $216,591 - $243,600	-3,650 Reduced 24.41%	11,304 $714,000
Q4 2020 Jun 15, 2021	BUY	$57.74 - $65.43 $863,443 - $978,440	14,954 New	14,954 $928,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Heartland Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Heartland Bank & Trust CO with notifications on news.